These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35071466)

  • 21. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
    Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
    Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
    Zheng X; Fan L; Zhou P; Ma H; Huang S; Yu D; Zhao L; Yang S; Liu J; Huang A; Cai C; Dai X; Zhang T
    Transl Oncol; 2017 Jun; 10(3):431-441. PubMed ID: 28448959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating Tumor Cells Predict Prognosis Following Tyrosine Kinase Inhibitor Treatment in EGFR-Mutant Non-Small Cell Lung Cancer Patients.
    Yang B; Qin A; Zhang K; Ren H; Liu S; Liu X; Pan X; Yu G
    Oncol Res; 2017 Nov; 25(9):1601-1606. PubMed ID: 28474575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aneuploid Circulating Tumor Cells as a Predictor of Response to Neoadjuvant Chemotherapy in Non-Small Cell Lung Cancer.
    Huang M; Ma Y; Lv C; Li S; Lu F; Zhang S; Wang DD; Lin PP; Yang Y
    Int J Gen Med; 2021; 14():6609-6620. PubMed ID: 34703281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating Tumor Cells and Metabolic Parameters in NSCLC Patients Treated with Checkpoint Inhibitors.
    Castello A; Carbone FG; Rossi S; Monterisi S; Federico D; Toschi L; Lopci E
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32092983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancer.
    Hsu CL; Tsai TH; Huang CK; Yang CY; Liao WY; Ho CC; Ruan SY; Chen KY; Shih JY; Yang PC
    Lung Cancer; 2021 Jun; 156():50-58. PubMed ID: 33894494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between circulating tumour cell count and prognosis following chemotherapy in patients with advanced non-small-cell lung cancer.
    Zhang Z; Xiao Y; Zhao J; Chen M; Xu Y; Zhong W; Xing J; Wang M
    Respirology; 2016 Apr; 21(3):519-25. PubMed ID: 26661896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of circulating tumour cells and tumour marker detection in the chemotherapeutic evaluation of advanced colorectal cancer.
    Shen F; Zhu Y; Wang F; Cai X; Ding H; Zhou F; Wang J; Gu H; Liu C; Li Q
    Colorectal Dis; 2022 Jan; 24(1):68-76. PubMed ID: 34611964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of circulating tumor cells in advanced gastric cancer patients receiving chemotherapy.
    Liu Y; Ling Y; Qi Q; Lan F; Zhu M; Zhang Y; Bao Y; Zhang C
    Mol Clin Oncol; 2017 Feb; 6(2):235-242. PubMed ID: 28357102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of serum human epithelial growth factor receptor 2 extracellular domain and circulating tumor cells in evaluating therapeutic response in advanced gastric cancer].
    Li Y; Peng Z; Zhang X; Gong J; Shen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Nov; 20(11):1293-1299. PubMed ID: 29178102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of circulating tumor cells in non-small cell lung cancer patients undergoing chemotherapy.
    Tong B; Xu Y; Zhao J; Chen M; Xing J; Zhong W; Wang M
    Oncotarget; 2017 Oct; 8(49):86615-86624. PubMed ID: 29156821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Karyotyping of circulating tumor cells for predicting chemotherapeutic sensitivity and efficacy in patients with esophageal cancer.
    Chen Y; Yang Z; Wang Y; Wang J; Wang C
    BMC Cancer; 2019 Jul; 19(1):651. PubMed ID: 31269908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy.
    Shen J; Zhao J; Jiang T; Li X; Zhao C; Su C; Zhou C
    Oncotarget; 2017 Jul; 8(30):49044-49052. PubMed ID: 28467771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer.
    Barbazán J; Muinelo-Romay L; Vieito M; Candamio S; Díaz-López A; Cano A; Gómez-Tato A; Casares de Cal Mde L; Abal M; López-López R
    Int J Cancer; 2014 Dec; 135(11):2633-43. PubMed ID: 24752533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The value of circulating tumor cells detected by chromosome centromere probe identification in diagnosis of non-small cell lung cancer].
    Shen Q; Shen LS; Chen Q; Zhou JY; Zhou JY
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Oct; 41(10):772-777. PubMed ID: 30347548
    [No Abstract]   [Full Text] [Related]  

  • 36. Epithelial-Mesenchymal-Transition-Like Circulating Tumor Cell-Associated White Blood Cell Clusters as a Prognostic Biomarker in HR-Positive/HER2-Negative Metastatic Breast Cancer.
    Guan X; Li C; Li Y; Wang J; Yi Z; Liu B; Chen H; Xu J; Qian H; Xu B; Ma F
    Front Oncol; 2021; 11():602222. PubMed ID: 34150608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The longitudinal change of circulating tumor cell during chemotherapy and its correlation with disease features, treatment response and survival profile of advanced gallbladder carcinoma.
    Wang Y; Yuan Z; Zhu S; Bao X; Fu Z; Zhen T; Xing K; Zhang Y; Li X; Sun J; Li Q; Wu L
    Am J Transl Res; 2021; 13(12):13590-13598. PubMed ID: 35035699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PD-L1
    Zhang L; Zhang X; Liu Y; Zhang T; Wang Z; Gu M; Li Y; Wang DD; Li W; Lin PP
    Cancer Lett; 2020 Jan; 469():355-366. PubMed ID: 31678168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Application of Circulating Tumor Cells and Circulating Endothelial Cells in Predicting Bladder Cancer Prognosis and Neoadjuvant Chemosensitivity.
    Yang X; Lv J; Zhou Z; Feng D; Zhou R; Yuan B; Wu Q; Yu H; Han J; Cao Q; Gu M; Li P; Yang H; Lu Q
    Front Oncol; 2021; 11():802188. PubMed ID: 35186716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.
    Larsson AM; Jansson S; Bendahl PO; Levin Tykjaer Jörgensen C; Loman N; Graffman C; Lundgren L; Aaltonen K; Rydén L
    Breast Cancer Res; 2018 Jun; 20(1):48. PubMed ID: 29884204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.